Literature DB >> 26743518

Role of microRNA in regulating cell signaling pathways, cell cycle, and apoptosis in non-small cell lung cancer.

D K Singh, S Bose, S Kumar1.   

Abstract

Dysregulation in expression of miRNAs has been observed in various human cancers, including lung cancer. Recent studies have identified the role of a number of miRNAs in regulating key cellular processes and signaling pathways involved in lung tumourigenesis, including cell proliferation, differentiation, angiogenesis, apoptosis, invasion and metastasis. Due to their variable behavior and regulatory role in various nodal junctions in cellular pathways, miRNAs have also been used as potential therapeutic targets and clinical biomarkers in lung cancer. In this non-systematic review, we briefly focus on biogenesis and function of cytoplasmic miRNA and the role of methylation in the regulation of miRNA biogenesis in non-small cell lung cancer (NSCLC). Further, we elaborate on the role of differentially expressed miRNAs and their regulatory role on various signaling pathways, cell cycle, and apoptosis in NSCLC.

Entities:  

Year:  2016        PMID: 26743518

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  5 in total

1.  TTCA: an R package for the identification of differentially expressed genes in time course microarray data.

Authors:  Marco Albrecht; Damian Stichel; Benedikt Müller; Ruth Merkle; Carsten Sticht; Norbert Gretz; Ursula Klingmüller; Kai Breuhahn; Franziska Matthäus
Journal:  BMC Bioinformatics       Date:  2017-01-14       Impact factor: 3.169

2.  Analysis of miR-375-3p, miR-197-3p, and miR-15a-5p Expression and Their Clinical Relevance as Biomarkers in Lung Cancer.

Authors:  Sachin Kumar; Jyoutishman Saikia; Surender K Sharawat; Prabhat S Malik; Sunil Kumar; Anant Mohan
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

3.  miRNA‑504 inhibits p53‑dependent vascular smooth muscle cell apoptosis and may prevent aneurysm formation.

Authors:  Xue Cao; Zhenguo Cai; Junyan Liu; Yanru Zhao; Xin Wang; Xueqi Li; Hongyuan Xia
Journal:  Mol Med Rep       Date:  2017-06-28       Impact factor: 2.952

4.  Long noncoding RNA TTN-AS1 enhances the malignant characteristics of osteosarcoma by acting as a competing endogenous RNA on microRNA-376a thereby upregulating dickkopf-1.

Authors:  Shenglong Li; Fei Liu; Yi Pei; Wei Wang; Ke Zheng; Xiaojing Zhang
Journal:  Aging (Albany NY)       Date:  2019-09-16       Impact factor: 5.682

5.  Targeted delivery of small noncoding RNA for glioblastoma.

Authors:  Ji Young Yoo; Margaret Yeh; Balveen Kaur; Tae Jin Lee
Journal:  Cancer Lett       Date:  2020-11-08       Impact factor: 8.679

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.